Cargando…

Intensity-modulated radiotherapy for squamous cell carcinoma of the anal canal: Efficacy of a low daily dose to clinically negative regions

BACKGROUND: We aimed to assess outcomes of patients with anal cancer who underwent intensity-modulated radiotherapy (IMRT) and received less than 1.80 Gy/day. METHODS: We retrospectively reviewed our experience using a low fractional dose (< 1.80 Gy) of IMRT to elective nodal areas for patients r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Call, Jason A, Haddock, Michael G, Quevedo, J Fernando, Larson, David W, Miller, Robert C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198694/ https://www.ncbi.nlm.nih.gov/pubmed/21978568 http://dx.doi.org/10.1186/1748-717X-6-134

Ejemplares similares

Intensity modulated radiotherapy for anal canal squamous cell carcinoma: A 16-year single institution experience
por: Jethwa, Krishan R., et al.
Publicado: (2021)

Intensity-modulated radiotherapy for synchronous cancer of the anal canal and cervix
por: Kawamoto, Terufumi, et al.
Publicado: (2018)

Efficacy and tolerance of high-dose-rate brachytherapy boost after external radiotherapy in the treatment of squamous cell carcinoma of the anal canal
por: Bertin, Emilien, et al.
Publicado: (2018)

The impact of anaemia on treatment outcome in patients with squamous cell carcinoma of anal canal and anal margin
por: Oblak, Irena, et al.
Publicado: (2016)

IMRT, RapidArc® and conformal radiotherapy in the treatment of tumours of the anal canal
por: Cendales, Ricardo, et al.
Publicado: (2014)

Melanoma of the anal canal
por: Parra, Rogerio Serafim, et al.
Publicado: (2010)

Narrow-band imaging for diagnosis of squamous cell carcinoma in the anal canal
por: Takeuchi, Yoji, et al.
Publicado: (2017)

Intensity-Modulated Radiotherapy (IMRT) vs Helical Tomotherapy (HT) in Concurrent Chemoradiotherapy (CRT) for Patients with Anal Canal Carcinoma (ACC): an analysis of dose distribution and toxicities
por: Yeung, Rosanna, et al.
Publicado: (2015)

Beware of anal fissures: pemphigus vulgaris of the anal canal
por: Karatzi, Chara, et al.
Publicado: (2019)

Chemoradiotherapy in squamous cell carcinoma of the anal canal: a single institution experience
por: Kim, Kyung Hwan, et al.
Publicado: (2013)

Early Squamous Cell Carcinoma of the Anal Canal Resected by Endoscopic Submucosal Dissection
por: Tamaru, Yuzuru, et al.
Publicado: (2015)

Endoscopic submucosal dissection to treat squamous cell carcinoma in situ of the anal canal
por: Lajin, Michael, et al.
Publicado: (2022)

Interstitial high-dose rate brachytherapy as boost for anal canal cancer
por: Falk, Alexander Tuan, et al.
Publicado: (2014)

Anal canal cancer treatment: practical limitations of routine prescription of concurrent chemotherapy and radiotherapy
por: Chauveinc, L, et al.
Publicado: (2003)

Is elective inguinal radiotherapy necessary for locally advanced rectal adenocarcinoma invading anal canal?
por: Yeo, Seung-Gu, et al.
Publicado: (2014)

HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53
por: Meulendijks, D, et al.
Publicado: (2015)

Dosimetric advantages and clinical outcomes of simultaneous integrated boost intensity-modulated radiotherapy for anal squamous cell carcinoma
por: Sakanaka, Katsuyuki, et al.
Publicado: (2017)

Dose planning objectives in anal canal cancer IMRT: the TROG ANROTAT experience
por: Brown, Elizabeth, et al.
Publicado: (2015)

Anal canal to pubis angle: a novel clinical ultrasound technique for the assessment of the anorectal region
por: Asfour, Victoria, et al.
Publicado: (2021)

Black Anal Canal: Acute Necrosis
por: Barbeiro, Sandra, et al.
Publicado: (2016)

A Case of Lymphangioma of the Anal Canal
por: Karapashis, Kyriacos, et al.
Publicado: (2018)

SMILE-like lesion in the anal canal
por: Sekar, Aravind, et al.
Publicado: (2021)

Characteristics of anal canal cancer in Japan
por: Yamada, Kazutaka, et al.
Publicado: (2022)

Vaginal Sparing Radiotherapy Using IMPT and Daily Dilator Placement for Women with Anal Cancer
por: Lester, Scott C., et al.
Publicado: (2022)

A Regimen of Taxol, Ifosfamide, and Platinum for Recurrent Advanced Squamous Cell Cancer of the Anal Canal
por: Golub, Diana V., et al.
Publicado: (2011)

Mitomycin and 5‐fluorouracil for second‐line treatment of metastatic squamous cell carcinomas of the anal canal
por: Saint, Angélique, et al.
Publicado: (2019)

Intensity-Modulated Radiotherapy Associated With Improved Survival Outcome in Anal Cancer
por: Mohamed, Ahmed Allam, et al.
Publicado: (2022)

Cloacal type defect of the anal canal following an obstetric anal sphincter trauma
por: Stavros, Sofoklis, et al.
Publicado: (2021)

Late Gastrointestinal Tolerance After Prostate Radiotherapy: Is the Anal Canal the Culprit? A Narrative Critical Review
por: Sargos, Paul, et al.
Publicado: (2021)

Estimated dose to site of loco-regional recurrence after radiotherapy in anal cancer using point of origin methods
por: Lycke Wind, Karen, et al.
Publicado: (2023)

Metachronous tubulovillous and tubular adenomas of the anal canal
por: Nozawa, Hiroaki, et al.
Publicado: (2015)

A Bleeding Dieulafoy's Lesion in the Anal Canal
por: Gurala, Dhineshreddy, et al.
Publicado: (2019)

Betapapillomaviruses in the anal canal of HIV positive and HIV negative men who have sex with men
por: Poljak, Mario, et al.
Publicado: (2014)

Stage IV anal canal squamous cell carcinoma with long-term survival: a case report
por: Sawai, Katsuji, et al.
Publicado: (2022)

Hepatic Metastasectomy in Squamous Cell Carcinoma of the Anal Canal: A Case Series of a Curative Approach
por: Rogers, Jane E., et al.
Publicado: (2023)

Nonplatinum‐based therapy with Paclitaxel and Capecitabine for advanced squamous cell carcinomas of the anal canal: A population‐based Danish anal cancer group study
por: Truelsen, Christina Glismand, et al.
Publicado: (2021)

VITAL phase 2 study: Upfront 5‐fluorouracil, mitomycin‐C, panitumumab and radiotherapy treatment in nonmetastatic squamous cell carcinomas of the anal canal (GEMCAD 09‐02)
por: Feliu, Jaime, et al.
Publicado: (2019)

Anal Canal Duplication in a 25-Year-Old Female Patient
por: Gutierrez-Alvarez, Mauricio, et al.
Publicado: (2023)

Definitive Radiotherapy for Patients With Anal Squamous Cell Carcinoma: A Retrospective Cohort Study
por: Katano, Atsuto, et al.
Publicado: (2021)

Online daily assessment of dose change in head and neck radiotherapy without dose‐recalculation
por: Vickress, Jason R., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cllert2le7nu6durhalghp6r8d